The U.S. Surgical Dressings Market was valued at USD 1.52 Billion in 2024, and is projected to reach USD 1.94 Billion by 2030, rising at a CAGR of 4.09%. The rising number of surgical procedures and the growing prevalence of chronic wounds, such as diabetic foot ulcers & pressure ulcers, are some of the factors driving the market growth. According to data published by the Agency for Healthcare Research and Quality in February 2024, approximately 2.5 million people develop pressure ulcers in the U.S. Furthermore, innovations like smart dressings and 3D printing are anticipated to boost the effectiveness of surgical dressings.
Moreover, the increasing prevalence of organ transplant surgeries significantly drives the surgical dressings market due to the heightened demand for specialized wound care products post-surgery. For instance, as per a report by the Organ Procurement and Transplantation Network, in January 2025, around 48,149 transplants were performed in the U.S., marking a 3.3 percent increase compared to the total in 2023 and a 23.3 percent rise over the past five years in the U.S. As organ transplant surgeries rise, the need for advanced wound care solutions such as antibacterial dressings, hydrocolloids, hydrogels, and film dressings is anticipated to increase. These dressings offer optimal moisture balance, enhance healing, and provide antimicrobial properties, essential for patients recovering from invasive surgeries like organ transplants.
The growing prevalence of chronic and acute wounds, including diabetic ulcers, pressure ulcers, burns, and venous leg ulcers, is the key factor driving the growth of the U.S. surgical dressings market. This rise is mainly due to the increasing incidence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. According to CDC data published in December 2023, around 96 million adults (38% of U.S. adults) have prediabetes, with over 80% unaware of their condition. Diabetic foot ulcers are a common complication of severe diabetes, while pressure ulcers often occur in cancer patients.
Therefore, the high burden of these chronic diseases is expected to boost the demand for surgical dressings to manage wounds arising from surgical procedures related to these conditions.
In addition, there has been a significant rise in cosmetic surgical procedures. Data released by Discovery ABA in February 2024 reveals that roughly 26.2 million surgical and minimally invasive reconstructive and cosmetic procedures were performed in 2022 in the U.S., reflecting a significant 19% increase in cosmetic surgeries since 2019. Surgical dressings are utilized during aesthetic and plastic surgeries. Thus, the growing number of cosmetic surgical procedures is projected to further enhance market growth over the forecast period.
This product will be delivered within 1-3 business days.
Moreover, the increasing prevalence of organ transplant surgeries significantly drives the surgical dressings market due to the heightened demand for specialized wound care products post-surgery. For instance, as per a report by the Organ Procurement and Transplantation Network, in January 2025, around 48,149 transplants were performed in the U.S., marking a 3.3 percent increase compared to the total in 2023 and a 23.3 percent rise over the past five years in the U.S. As organ transplant surgeries rise, the need for advanced wound care solutions such as antibacterial dressings, hydrocolloids, hydrogels, and film dressings is anticipated to increase. These dressings offer optimal moisture balance, enhance healing, and provide antimicrobial properties, essential for patients recovering from invasive surgeries like organ transplants.
The growing prevalence of chronic and acute wounds, including diabetic ulcers, pressure ulcers, burns, and venous leg ulcers, is the key factor driving the growth of the U.S. surgical dressings market. This rise is mainly due to the increasing incidence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. According to CDC data published in December 2023, around 96 million adults (38% of U.S. adults) have prediabetes, with over 80% unaware of their condition. Diabetic foot ulcers are a common complication of severe diabetes, while pressure ulcers often occur in cancer patients.
Therefore, the high burden of these chronic diseases is expected to boost the demand for surgical dressings to manage wounds arising from surgical procedures related to these conditions.
In addition, there has been a significant rise in cosmetic surgical procedures. Data released by Discovery ABA in February 2024 reveals that roughly 26.2 million surgical and minimally invasive reconstructive and cosmetic procedures were performed in 2022 in the U.S., reflecting a significant 19% increase in cosmetic surgeries since 2019. Surgical dressings are utilized during aesthetic and plastic surgeries. Thus, the growing number of cosmetic surgical procedures is projected to further enhance market growth over the forecast period.
U.S. Surgical Dressings Market Report: Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the U.S. surgical dressings market report based on product, application, and end use:Product Outlook (Revenue, USD Million, 2018-2030)
- Primary
- Secondary
- Others
Application Outlook (Revenue, USD Million, 2018-2030)
- Diabetes related surgeries
- Cardiovascular related surgeries
- Ulcers
- Burns
- Transplant Sites
- Others
End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Specialty Clinics
- Home Healthcare
- Ambulatory Surgery Centers
- Others
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Surgical Dressings Market Variables, Trends, & Scope
Chapter 4. U.S. Surgical Dressings Market: Product Estimates & Trend Analysis
Chapter 5. U.S. Surgical Dressings Market: Application Estimates & Trend Analysis
Chapter 6. U.S. Surgical Dressings Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The companies profiled in this U.S. Surgical Dressings market report include:- Smith+Nephew
- Mölnlycke Health Care AB
- Convatec Group PLC
- Essity
- DeRoyal Industries, Inc.
- Coloplast Corp
- 3M
- INTEGRA LIFESCIENCES
- Medline Industries, LP.
- Cardinal Health
- MIMEDX Group, Inc.
- Urgo Medical North America
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1.52 Billion |
| Forecasted Market Value ( USD | $ 1.94 Billion |
| Compound Annual Growth Rate | 4.0% |
| Regions Covered | United States |
| No. of Companies Mentioned | 13 |
